Biotech Values

[10nisman]

SFCC...

Does anyone know anything about this company? TIA, 10nis

http://biz.yahoo.com/bw/051116/20051116005914.html?.v=1

MIAMI--(BUSINESS WIRE)--Nov. 16, 2005--SFBC International, Inc. (NASDAQ:SFCC - News), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, today was the subject of another article by a Bloomberg reporter. This is the second article that has questioned the company's processes for conducting trials. The initial article included SFBC within a much larger attack on the pharmaceutical industry. The latest, much shorter article focuses on SFBC. The assertions from "anonymous sources" concerning coercion and threats by SFBC employees, including contacting immigration authorities are baseless. In fact, Arnold Hantman, chief executive officer of SFBC International, has never met with any of the participants contrary to the reporting in the article and, to the best of his knowledge, none of the participants have ever met him. The participants were specifically told they will not be allowed to take part in further SFBC trials for the simple but important reason that they admitted to Bloomberg magazine that they falsified forms and presented false government identification. In addition, these participants violated the Confidentiality Agreement which is part of the consent form process.

SFBC believes there is no merit for the criticism of its practices. The information in both articles is inaccurate, and in the second article the information is just untrue. SFBC takes its responsibilities seriously to its clients, to federal and state regulators protecting human subjects, and to the people who volunteer to participate in its studies.

The processes the Company follows are fully compliant with all regulations and ethical standards. SFBC has never received a warning letter from FDA. SFBC has built its business around an excellent record of compliance and high quality studies. SFBC's clients have indicated they support its work.

SFBC obtains consents from all of the individuals who participate in its clinical trials and each participant voluntarily confirms his or her willingness to participate in a specific clinical trial only after being provided with full information regarding the clinical trial. SFBC takes very seriously both compliance with the law and all ethical guidelines. In obtaining consents from participants, SFBC follows good clinical practice guidelines, the principles of the Declaration of Helsinki, and the human subject protection requirements of 21 CFR Parts 50, 56, 312 and 314 and the ICH E-6. In addition, the Company is looking into adding an additional process of recording the consent process. SFBC continuously looks for additional ways to improve all of its processes.

SFBC remains committed to conducting the highest quality research. SFBC has every reason to believe that its clients will recognize the Company's good work and continue to maintain a high level of trust that the studies it conducts are of the highest quality.

About SFBC International, Inc.

SFBC International, Inc. provides early and late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world. SFBC has more than 30 offices located in North America, Europe (including Central and Eastern Europe), South America, Asia, and Australia. In early clinical development services, SFBC specializes primarily in the areas of Phase I and early Phase II clinical trials and bioanalytical laboratory services, including early clinical pharmacology. SFBC also provides late stage clinical development services globally that focus on Phase II through IV clinical trials. SFBC also offers a range of complementary services, including data management and biostatistics, central laboratory services, medical and scientific affairs, regulatory affairs and submissions, and clinical IT solutions. Additional information is available on SFBC's website at http://www.sfbci.com.

Contact:
SFBC International, Miami
Carmen Bratter, 305-895-0304
or
Financial Dynamics
Evan Smith, CFA / Erica Pettit
212-850-5606 / 212-850-5614